These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15137109)
1. Surface-enhanced Raman spectroscopy study of the interaction of the antitumoral drug emodin with human serum albumin. Fabriciova G; Sanchez-Cortes S; Garcia-Ramos JV; Miskovsky P Biopolymers; 2004 May-Jun 5; 74(1-2):125-30. PubMed ID: 15137109 [TBL] [Abstract][Full Text] [Related]
2. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. Bhattacharya AA; Grüne T; Curry S J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971 [TBL] [Abstract][Full Text] [Related]
3. Structural requirements for drug binding to site II on human serum albumin. Wanwimolruk S; Birkett DJ; Brooks PM Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516 [TBL] [Abstract][Full Text] [Related]
4. Identification of the antitumoral drug emodin binding sites in bovine serum albumin by spectroscopic methods. Sevilla P; Rivas JM; García-Blanco F; García-Ramos JV; Sánchez-Cortés S Biochim Biophys Acta; 2007 Nov; 1774(11):1359-69. PubMed ID: 17945545 [TBL] [Abstract][Full Text] [Related]
5. In vitro binding of leukotriene B4 (LTB4) to human serum albumin: evidence from spectroscopic, molecular modeling, and competitive displacement studies. Zsila F; Bikádi Z; Lockwood SF Bioorg Med Chem Lett; 2005 Aug; 15(16):3725-31. PubMed ID: 15993588 [TBL] [Abstract][Full Text] [Related]
6. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies. Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067 [TBL] [Abstract][Full Text] [Related]
7. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. Simard JR; Zunszain PA; Hamilton JA; Curry S J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140 [TBL] [Abstract][Full Text] [Related]
8. Binding of the bioactive compound 5,7,4'-trihydroxy-6,3',5'-trimethoxyflavone to human serum albumin. Tang J; Wang W; Luan F; Chen X Int J Biol Macromol; 2005 Oct; 37(1-2):85-91. PubMed ID: 16219344 [TBL] [Abstract][Full Text] [Related]
9. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability. Kurono M; Fujii A; Murata M; Fujitani B; Negoro T Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683 [TBL] [Abstract][Full Text] [Related]
10. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids. Fujiwara S; Amisaki T Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783 [TBL] [Abstract][Full Text] [Related]
12. Heme impairs allosterically drug binding to human serum albumin Sudlow's site I. Ascenzi P; Bocedi A; Notari S; Menegatti E; Fasano M Biochem Biophys Res Commun; 2005 Aug; 334(2):481-6. PubMed ID: 16004963 [TBL] [Abstract][Full Text] [Related]
13. Changes of serum albumin affinity for aspirin induced by fatty acid. Bojko B; Sułkowska A; Maciazek M; Równicka J; Njau F; Sułkowski WW Int J Biol Macromol; 2008 May; 42(4):314-23. PubMed ID: 18346781 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of the drug-binding specificity of human serum albumin. Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013 [TBL] [Abstract][Full Text] [Related]
15. Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies. Khan SN; Islam B; Yennamalli R; Sultan A; Subbarao N; Khan AU Eur J Pharm Sci; 2008 Dec; 35(5):371-82. PubMed ID: 18762252 [TBL] [Abstract][Full Text] [Related]
16. Binding to human serum albumin of zidovudine (AZT) and novel AZT derivatives. Experimental and theoretical analyses. Quevedo MA; Ribone SR; Moroni GN; Briñón MC Bioorg Med Chem; 2008 Mar; 16(6):2779-90. PubMed ID: 18249551 [TBL] [Abstract][Full Text] [Related]
17. pH-dependent complexation of histamine H1 receptor antagonists and human serum albumin studied by UV resonance Raman spectroscopy. Tardioli S; Buijs J; Gooijer C; van der Zwan G J Phys Chem B; 2012 Mar; 116(12):3808-15. PubMed ID: 22372713 [TBL] [Abstract][Full Text] [Related]
18. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements. Lucas LH; Price KE; Larive CK J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793 [TBL] [Abstract][Full Text] [Related]
19. Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods. Tang K; Qin YM; Lin AH; Hu X; Zou GL J Pharm Biomed Anal; 2005 Sep; 39(3-4):404-10. PubMed ID: 15964731 [TBL] [Abstract][Full Text] [Related]
20. In silico prediction of drug-binding strengths to human serum albumin. Colmenarejo G Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]